Sign in

CIK 0000072444

  • Accelerated filer
  • Smaller reporting company

Vaxart, Inc.

Sign in to watch
Ticker
VXRT
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
591212264
Phone
+1 650-550-3500
Business address
310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
Former names
Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2010-03-18 Aryeh Jason Director Sale −6,381 $5.96 $38K 352,820
2010-03-18 Aryeh Jason Director Sale −200 $5.97 $1K 352,620
2010-03-17 Aryeh Jason Director Sale −8,800 $5.94 $52K 361,820
2010-03-17 Aryeh Jason Director Sale −2,619 $5.96 $16K 359,201
2010-03-17 Kalnik Matthew W. SVP Strategic Plan. & Bus. Ops Sale −9,873 $5.93 $59K 29,650.1
2010-03-15 Kessler Paul D. SVP Clinical, Med. & Reg.; CMO Grant or award · Stock Option (right to buy) +1,000 1,000
2010-03-15 Aryeh Jason Director Sale −200 $5.93 $1K 370,620
2010-03-12 Aryeh Jason Director Sale −600 $5.93 $4K 386,820
2010-03-12 Aryeh Jason Director Sale −16,000 $5.93 $95K 370,820
2010-03-11 Kalnik Matthew W. SVP Strategic Plan. & Bus. Ops Exercise or conversion +1,125 $3.95 $4K 40,648.1
2010-03-11 Kalnik Matthew W. SVP Strategic Plan. & Bus. Ops Sale −1,125 $5.95 $7K 39,523.1
2010-03-11 Kalnik Matthew W. SVP Strategic Plan. & Bus. Ops Exercise or conversion · Stock Option (Right to Buy) −1,125 14,625
2010-03-11 Aryeh Jason Director Sale −180,700 $5.88 $1.1M 387,420
2010-03-10 Aryeh Jason Director Sale −16,100 $5.74 $92K 568,120
2010-03-08 Aryeh Jason Director Sale −3,200 $5.75 $18K 584,220
2010-03-02 Kalnik Matthew W. SVP Strategic Plan. & Bus. Ops Exercise or conversion +2,250 $3.95 $9K 41,773.1
2010-03-02 Kalnik Matthew W. SVP Strategic Plan. & Bus. Ops Sale −2,250 $5.45 $12K 39,523.1
2010-03-02 Kalnik Matthew W. SVP Strategic Plan. & Bus. Ops Exercise or conversion · Stock Option (Right to Buy) −2,250 15,750
2010-01-13 Aryeh Jason Director Sale −13,800 $5.49 $76K 587,420
2010-01-12 Aryeh Jason Director Sale −86,200 $5.49 $473K 601,220

Page 31 of 42 · 830 trades